Anagrelide hydrochlorideProduct ingredient for Anagrelide

Anagrelide is a platelet-reducing agent used to lower dangerously elevated platelet levels (i.e. to treat thrombocythemia) in patients with myeloproliferative neoplasms.⁹ It is an oral imidazoquinazoline that was first approved for use in the US in 1997.⁸ It appears to carry a better response rate than other thrombocythemia treatments (e.g. busulfan, hydroxyurea) and may be better tolerated.⁸